Biblio
Found 4 results
Filters: Keyword is Neoplasm Recurrence, Local [Clear All Filters]
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.
.
2023. Proton therapy for head and neck paragangliomas: A single institutional experience.. Head Neck. 42(4):670-677.
.
2020. .
2019.
Volumetric Growth Rate of Recurrent Pleomorphic Adenoma.. Ann Otol Rhinol Laryngol. 126(7):544-547.
.
2017.